Atlas Trials

Time Course of the Antiproteinuric and Blood Pressure Lowering Effects After Initiation of Renin Inhibition With Aliskiren in Type 2 Diabetes

Clinical trial NCT00461136 · COMPLETED

Trial details

NCT number
NCT00461136
Sponsor
Novartis
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Diabetes Type 2
Start date
2005-08-01
Primary completion
2006-11-01
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.